相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Prevalence of patients with rheumatoid arthritis and age-stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan
Ayako Nakajima et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2020)
Expert endoscopists with high adenoma detection rates frequently detect diminutive adenomas in proximal colon
Osamu Toyoshima et al.
ENDOSCOPY INTERNATIONAL OPEN (2020)
Complex Relationships of Smoking, HLA-DRB1 Genes, and Serologic Profiles in Patients With Early Rheumatoid Arthritis: Update From a Swedish Population-Based Case-Control Study
Anna Karin Hedstrom et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor
Yuki Ishikawa et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis
Kensuke Oryoji et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se
Dan Murphy et al.
PLOS ONE (2017)
Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching
Satoshi Kubo et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial
Jeremy Sokolove et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Association of HLA-DRB1 Haplotypes With Rheumatoid Arthritis Severity, Mortality, and Treatment Response
Sebastien Viatte et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside
Yoshiya Tanaka
JOURNAL OF BIOCHEMISTRY (2015)
Association of Valine and Leucine at HLA-DRB1 Position 11 With Radiographic Progression in Rheumatoid Arthritis, Independent of the Shared Epitope Alleles but Not Independent of Anti-Citrullinated Protein Antibodies
H. W. van Steenbergen et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Selecting an Appropriate Caliper Can Be Essential for Achieving Good Balance With Propensity Score Matching
Mark Lunt
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
Michael Schiff et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical
Yoshiya Tanaka et al.
Modern Rheumatology (2014)
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Jennifer Pieper et al.
BMC IMMUNOLOGY (2013)
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Gerd R. Burmester et al.
LANCET (2013)
Quantitative effect of HLA-DRB1 alleles to ACPA levels in Japanese rheumatoid arthritis: no strong genetic impact of shared epitope to ACPA levels after stratification of HLA-DRB1*09:01
Chikashi Terao et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis
Judit Laki et al.
ARTHRITIS AND RHEUMATISM (2012)
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald F. van Vollenhoven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA)
Chun Lai Too et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Subcutaneous Abatacept Versus Intravenous Abatacept A Phase IIIb Noninferiority Study in Patients With an Inadequate Response to Methotrexate
M. C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
Peter C. Austin
PHARMACEUTICAL STATISTICS (2011)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
The rheumatoid arthritis HLA-DRB1 shared epitope
Joseph Holoshitz
CURRENT OPINION IN RHEUMATOLOGY (2010)
New insights into the regulation of T cells by γc family cytokines
Yrina Rochman et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
M. Schiff et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis
Henrik Kallberg et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis
AHM van der Helm-van Mil et al.
ARTHRITIS AND RHEUMATISM (2006)
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins
TWJ Huizinga et al.
ARTHRITIS AND RHEUMATISM (2005)
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition
MC Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis
C Turesson et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
D Aletaha et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Impact of shared epitope genotype and ethnicity on erosive disease - A meta-analysis of 3,240 rheumatoid arthritis patients
JD Gorman et al.
ARTHRITIS AND RHEUMATISM (2004)
The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept
LA Criswell et al.
ARTHRITIS AND RHEUMATISM (2004)
Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis
JD Gorman et al.
ARTHRITIS AND RHEUMATISM (2004)
Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis
U Wagner et al.
RHEUMATOLOGY (2003)
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
JS Smolen et al.
RHEUMATOLOGY (2003)
分享论文
